title: Aliphatic acetogenin constituents of avocado fruits inhibit human oral cancer cell proliferation by targeting the EGFR/RAS/RAF/MEK/ERK1/2 pathway.
abstract: Avocado (Persea americana) fruits are consumed as part of the human diet and extracts have shown growth inhibitory effects in various types of human cancer cells, although the effectiveness of individual components and their underlying mechanism are poorly understood. Using activity-guided fractionation of the flesh of avocado fruits, a chloroform-soluble extract (D003) was identified that exhibited high efficacy towards premalignant and malignant human oral cancer cell lines. From this extract, two aliphatic acetogenins of previously known structure were isolated, compounds 1 [(2S,4S)-2,4-dihydroxyheptadec-16-enyl acetate] and 2 [(2S,4S)-2,4-dihydroxyheptadec-16-ynyl acetate]. In this study, we show for the first time that the growth inhibitory efficacy of this chloroform extract is due to blocking the phosphorylation of EGFR (Tyr1173), c-RAF (Ser338), and ERK1/2 (Thr202/Tyr204) in the EGFR/RAS/RAF/MEK/ERK1/2 cancer pathway. Compounds 1 and 2 both inhibited phosphorylation of c-RAF (Ser338) and ERK1/2 (Thr202/Tyr204). Compound 2, but not compound 1, prevented EGF-induced activation of the EGFR (Tyr1173). When compounds 1 and 2 were combined they synergistically inhibited c-RAF (Ser338) and ERK1/2 (Thr202/Tyr204) phosphorylation, and human oral cancer cell proliferation. The present data suggest that the potential anticancer activity of avocado fruits is due to a combination of specific aliphatic acetogenins that target two key components of the EGFR/RAS/RAF/MEK/ERK1/2 cancer pathway.
authors: Department of Radiology, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
authors: Steven M
authors: SM
authors: D'Ambrosio
authors: Chunhua
authors: C
authors: Han
authors: Li
authors: L
authors: Pan
authors: A Douglas
authors: AD
authors: Kinghorn
authors: Haiming
authors: H
authors: Ding
references: Int J Cancer. 2008 Dec 15;123(12):2923-30
references: 18798257
references: Phytomedicine. 1996 Nov;3(3):281-5
references: 23195084
references: FEBS J. 2010 Jan;277(2):301-8
references: 19922469
references: Nutr Cancer. 2005;51(2):207-17
references: 15860443
references: J Clin Oncol. 2009 Apr 20;27(12):2091-6
references: 19188670
references: Nat Rev Clin Oncol. 2010 Sep;7(9):493-507
references: 20551942
references: Trends Pharmacol Sci. 1999 Oct;20(10):408-12
references: 10577253
references: Biosci Biotechnol Biochem. 2000 Nov;64(11):2500-3
references: 11193427
references: Semin Cancer Biol. 2007 Oct;17(5):386-94
references: 17582784
references: Cell. 1994 Sep 23;78(6):949-61
references: 7923364
references: Br J Cancer. 1989 Apr;59(4):559-62
references: 2713242
references: J Nutr Biochem. 2005 Jan;16(1):23-30
references: 15629237
references: Oral Oncol. 2001 Oct;37(7):599-604
references: 11564582
references: Nat Rev Drug Discov. 2003 Apr;2(4):296-313
references: 12669029
references: Biosci Biotechnol Biochem. 2001 Jul;65(7):1656-8
references: 11515553
references: Cell Biol Toxicol. 1997 Oct;13(6):419-34
references: 9352120
references: FEBS J. 2010 Jan;277(2):309-15
references: 19922468
references: Biosci Biotechnol Biochem. 2000 Nov;64(11):2504-7
references: 11193428
references: Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8512-6
references: 8078913
references: Nutr Cancer. 2009;61(3):348-56
references: 19373608
references: Pure Appl Chem. 2009 Jan 1;81(6):1051-1063
references: 20046887
references: Lancet Oncol. 2008 Oct;9(10):962-72
references: 18804418
references: Cancer Res. 1989 Sep 1;49(17):4682-9
references: 2547513
references: Phytochemistry. 2000 May;54(2):183-9
references: 10872209